NIDA wishes to thank the following individuals for their guidance and comments during the development and review of this publication:
Karen L. Bierman, Ph.D.
Pennsylvania State University
|
Hyman Hops, Ph.D.
Oregon Research Institute
|
C. Hendricks Brown, Ph.D.
University of South Florida
|
Eugene R. Oetting, Ph.D.
Colorado State University
|
Richard R. Clayton, Ph.D.
University of Kentucky
|
Zili Sloboda, Sc.D.
University of Akron
|
Thomas J. Dishion, Ph.D.
University of Oregon
|
Richard Spoth, Ph.D.
Iowa State University
|
E. Michael Foster, Ph.D.
Pennsylvania State
|
John B. Reid, Ph.D.
University Oregon Social Learning Center
|
Meyer D. Glantz, Ph.D.
National Institute on Drug Abuse
|
Thomas A. Wills, Ph.D.
Albert Einstein College of Medicine
|
Mark T. Greenberg, Ph.D.
Pennsylvania State University
|
|
NIDA also would like to thank the Community Anti-Drug Coalitions of America (CADCA) for helping organize a focus group of community leaders in reviewing this publication.
This publication was written by Elizabeth B. Robertson, Ph.D., Susan L. David, M.P.H. (retired), and Suman A. Rao, Ph.D., National Institute on Drug Abuse.
All materials in this volume are in the public domain and may be used or reproduced without permission from NIDA or the authors. Citation of the source is appreciated.
The U.S. government does not endorse or favor any specific commercial product or company. Trade, proprietary, or company names appearing in the publication are used only because they are considered essential in the context of the studies described here.
NIH Publication No. 04-4212(B)
Printed 1997
Reprinted 1997, 1999, 2001
Second Edition October 2003
|